| Original language | English (US) |
|---|---|
| Pages (from-to) | 2971-2973 |
| Number of pages | 3 |
| Journal | Movement Disorders |
| Volume | 36 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2021 |
ASJC Scopus subject areas
- Neurology
- Clinical Neurology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Movement Disorders, Vol. 36, No. 12, 12.2021, p. 2971-2973.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Screening of GBA Mutations in Nigerian Patients with Parkinson's Disease
AU - Milanowski, Lukasz M.
AU - Oshinaike, Olajumoke
AU - Walton, Ronald L.
AU - Soto-Beasley, Alexandra I.
AU - Hanna Al-Shaikh, Rana
AU - Strongosky, Audrey J.
AU - Ross, Owen A.
AU - Wszolek, Zbigniew K.
AU - Ogun, Shamsideen Abayomi
N1 - Funding Information: : Mayo Clinic is an American Parkinson Disease Association (APDA) Mayo Clinic Information and Referral Center, an APDA Center for Advanced Research, and the Mayo Clinic Lewy Body Dementia Association Research Center of Excellence. L.M.M. is supported by the Polish National Agency for Academic Exchange Iwanowska's Fellowship PPN/IWA/2018/1/00006/U/00001/01. Z.K.W. is partially supported by the Mayo Clinic Center for Regenerative Medicine, Mayo Clinic in Florida Focused Research Team Program, the gifts from The Sol Goldman Charitable Trust, the Donald G. and Jodi P. Heeringa Family, the Haworth Family Professorship in Neurodegenerative Diseases fund, and The Albertson Parkinson's Research Foundation. He serves as principal investigator or co–principal investigator on Biohaven Pharmaceuticals, Inc. (BHV4157‐206 and BHV3241‐301) and Neuraly, Inc. (NLY01‐PD‐1) grants and as external advisory board member for the Vigil Neuroscience, Inc. He serves as co–principal investigator of the Mayo Clinic APDA Center for Advanced Research. Relevant conflicts of interest/financial disclosures Funding Information: We acknowledge our colleagues at the Lagos State University Teaching Hospital, Lagos, Nigeria, and the generous support of the patients and all individuals who donated biospecimens for study. L.M.M. is supported by the Polish National Agency for Academic Exchange Iwanowska's Fellowship PPN/IWA/2018/1/00006/U/00001/01. Z.K.W. is partially supported by the Mayo Clinic Center for Regenerative Medicine, Mayo Clinic in Florida Focused Research Team Program, the gifts from The Sol Goldman Charitable Trust, and the Donald G. and Jodi P. Heeringa Family, the Haworth Family Professorship in Neurodegenerative Diseases fund, and The Albertson Parkinson's Research Foundation. He serves as principal investigator or co–principal investigator on Biohaven Pharmaceuticals, Inc. (BHV4157-206 and BHV3241-301) and Neuraly, Inc. (NLY01-PD-1) grants and as external advisory board member for the Vigil Neuroscience, Inc. He serves as co–principal investigator of the Mayo Clinic American Parkinson Disease Association (APDA) Center for Advanced Research. O.A.R. is supported by the National Institutes of Health (R01 NS78086; U54 NS100693; U54 NS110435), the US Department of Defense (W81XWH-17-1-0249), The Little Family Foundation, Mayo Clinic Functional Genomics of LBD Program, the Mayo Clinic Center for Individualized Medicine, and The Michael J. Fox Foundation. Mayo Clinic is an APDA Mayo Clinic Information and Referral Center, an APDA Center for Advanced Research, and a Lewy Body Dementia Association Research Center of Excellence.
PY - 2021/12
Y1 - 2021/12
UR - https://www.scopus.com/pages/publications/85116025584
UR - https://www.scopus.com/pages/publications/85116025584#tab=citedBy
U2 - 10.1002/mds.28803
DO - 10.1002/mds.28803
M3 - Letter
C2 - 34586679
AN - SCOPUS:85116025584
SN - 0885-3185
VL - 36
SP - 2971
EP - 2973
JO - Movement Disorders
JF - Movement Disorders
IS - 12
ER -